These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3501902)
1. Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft. Thaulow E; Frøysaker T; Dale J; Vatne K Scand J Thorac Cardiovasc Surg; 1987; 21(3):215-20. PubMed ID: 3501902 [TBL] [Abstract][Full Text] [Related]
2. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC). Sanz G; Pajarón A; Alegría E; Coello I; Cardona M; Fournier JA; Gómez-Recio M; Ruano J; Hidalgo R; Medina A Circulation; 1990 Sep; 82(3):765-73. PubMed ID: 2203555 [TBL] [Abstract][Full Text] [Related]
3. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300 [TBL] [Abstract][Full Text] [Related]
4. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial. Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722 [TBL] [Abstract][Full Text] [Related]
5. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion. Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792 [TBL] [Abstract][Full Text] [Related]
6. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. Chesebro JH; Fuster V; Elveback LR; Clements IP; Smith HC; Holmes DR; Bardsley WT; Pluth JR; Wallace RB; Puga FJ N Engl J Med; 1984 Jan; 310(4):209-14. PubMed ID: 6361561 [TBL] [Abstract][Full Text] [Related]
7. Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study). Sanz G Thromb Res Suppl; 1990; 12():23-6. PubMed ID: 2082484 [TBL] [Abstract][Full Text] [Related]
8. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. Brown BG; Cukingnan RA; DeRouen T; Goede LV; Wong M; Fee HJ; Roth JA; Carey JS Circulation; 1985 Jul; 72(1):138-46. PubMed ID: 3874009 [TBL] [Abstract][Full Text] [Related]
9. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study. van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237 [TBL] [Abstract][Full Text] [Related]
10. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion. Brooks N; Wright J; Sturridge M; Pepper J; Magee P; Walesby R; Layton C; Honey M; Balcon R Br Heart J; 1985 Feb; 53(2):201-7. PubMed ID: 3881108 [TBL] [Abstract][Full Text] [Related]
11. The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts. Agnew TM; French JK; Neutze JM; Whitlock RM; Brandt PW; Kerr AR; Webber BJ; Rutherford JD Aust N Z J Med; 1992 Dec; 22(6):665-70. PubMed ID: 1489290 [TBL] [Abstract][Full Text] [Related]